1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Non-metastatic Prostate Cancer: new trials by email Literature Review of Non-metastatic Prostate Cancer trials Research Report on Non-metastatic Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer Darolutamide, Abemaciclib, GNRH-A Leuprolide Acetate - Metastatic Prostate Cancer, Non-metastatic Prostate Cancer | Phase 1 | Terminated | Praful Ravi, MB BCHir, MRCP | 9 | 2023-08-09 | 2026-10-15 |
| Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer Gefitinib, radiotherapy - Non-Metastatic Prostate Cancer | Phase 1 / Phase 2 | Completed | AstraZeneca | 42 | 2003-01-01 | 2009-04-23 |
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Gefitinib (1) · Goserelin (1) · Leuprolide (1) · Radiotherapy (1) · abemaciclib (1) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1) · darolutamide (1) · luprolide acetate gel depot (1)
AstraZeneca (1) · Praful Ravi, MB BCHir, MRCP (1)
Finland (1) · United States (1)
Praful Ravi, MB BChir, MRCP (1)
P50CA272390 (1)